tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
UK Market
AREC
Arecor Therapeutics PLC
RESEARCH TOOLSreports
Want to see GB:AREC full AI Analyst Report?

Arecor Therapeutics PLC (AREC) Stock News & Sentiment

6 Followers
Arecor Posts 2025 Annual Report and Sets Hybrid-Access AGM
Premium
Company Announcements
Arecor Posts 2025 Annual Report and Sets Hybrid-Access AGM
7d ago
Arecor boosts cash and partnerships as AT278 insulin heads toward Phase 2
Premium
Company Announcements
Arecor boosts cash and partnerships as AT278 insulin heads toward Phase 2
22d ago
Arecor sets April date for FY25 results as it advances ultra-rapid insulin and oral peptide platform
Premium
Company Announcements
Arecor sets April date for FY25 results as it advances ultra-rapid insulin and oral peptide platform
1M ago
Arecor Secures First Ligand Milestone to Advance Lead Insulin Program
Premium
Company Announcements
Arecor Secures First Ligand Milestone to Advance Lead Insulin Program
1M ago
Arecor to Spotlight Ultra-Concentrated Insulin AT278 at Key Diabetes and MedTech Conferences
Premium
Company Announcements
Arecor to Spotlight Ultra-Concentrated Insulin AT278 at Key Diabetes and MedTech Conferences
2M ago
Arecor sharpens diabetes focus as AT278 and oral peptide platform advance
Premium
Company Announcements
Arecor sharpens diabetes focus as AT278 and oral peptide platform advance
3M ago
Arecor and Sequel Med Tech to Host Virtual Panel on Future of Diabetes Treatment
Premium
Company Announcements
Arecor and Sequel Med Tech to Host Virtual Panel on Future of Diabetes Treatment
4M ago
More GB:AREC News >

AREC News on the Web

Arecor Therapeutics CEO on advancing ultra-rapid insulin trial and oral GLP-1 - ICYMI
Proactive Investors
Bullish
Arecor targets broader AT278 partnership as phase II trial nears
Proactive Investors
Neutral
Arecor boosts cash and partnerships as AT278 insulin heads toward Phase 2
TipRanks News
Neutral
Arecor sets April date for FY25 results as it advances ultra-rapid insulin and oral peptide platform
TipRanks News
Neutral
Arecor receives $500k milestone payment from Ligand as royalty deal delivers
Proactive Investors
Bullish
Arecor Secures First Ligand Milestone to Advance Lead Insulin Program
TipRanks News
Neutral
Arecor to Spotlight Ultra-Concentrated Insulin AT278 at Key Diabetes and MedTech Conferences
TipRanks News
Neutral
Arecor targets phase II trial for AT278 in 2026 - ICYMI
Proactive Investors
Bullish

News Score - Last 7 Days

Neutral
GB:AREC
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:AREC’s Media Buzz Sentiment?
1 articles about GB:AREC were published this week. In an average week, 1.5 articles are published.
    What is GB:AREC’s weekly average amount of articles?
    In an average week, 1.5 articles about GB:AREC are published.
      What is GB:AREC’s News Sentiment?
      100% of articles about GB:AREC were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week